Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Borba, Mayla Gabriela Silva, Val, Fernando Fonseca Almeida, Sampaio, Vanderson Souza, Alexandre, Marcia Almeida Araújo, Melo, Gisely Cardoso, Brito, Marcelo, Mourão, Maria Paula Gomes, Brito-Sousa, José Diego +21 more·2020·JAMA Network Open

DOI 10.1001/jamanetworkopen.2020.8857

Cited by (1,000)

Items 501–600 of 1,000

Coevolution of COVID-19 research and China’s policies
Xi Cheng, Li Tang, Maotian Zhou, Guoyan Wang · 2021 · Health Research Policy and Systems
Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses
Qinqin Sun, Xiaojuan Li, Ersheng Kuang · 2022 · Autophagy
Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
Josidel Conceição Oliver, Evandro Neves Silva, Letícia Martins Soares, Gislaine Cristina Scodeler, Ana de Souza Santos, Patrícia Paiva Corsetti, Carlos Roberto Prudêncio, Leonardo Augusto de Almeida · 2022 · Therapeutic Advances in Vaccines and Immunotherapy
Polypharmacology guided drug repositioning approach for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, Kikrusenuo Kiewhuo, Selvaraman Nagamani, Garikapati Narahari Sastry · 2023 · PLoS ONE
Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?
Christopher Wright, Carly Ross, Niall Mc Goldrick · 2020 · Evidence-Based Dentistry
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
Juan Jiménez‐Jáimez, Rosa Macías Ruiz, Francisco José Bermúdez-Jiménez, Ricardo Rubini-Costa, Jessica Ramírez-Taboada, Paula Isabel García Flores, Laura Gallo-Padilla, Juan Diego Mediavilla García, Concepción Morales García, Sara Moreno Suárez et al. · 2020 · Scientific Reports
Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
Sultan Ayoub Meo, Syed Ziauddin A. Zaidi, Trisha Shang, Jennifer Y. Zhang, Thamir Al-khlaiwi, Ishfaq Ali Bukhari, Javed Akram, David Charles Klonoff · 2020 · Journal of King Saud University - Science
Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 – 3. Version
Stefan Kluge, Uwe Janssens, Tobias Welte, Steffen Weber‐Carstens, Gereon Schälte, Bernd Salzberger, Petra Gastmeier, Florian Peter Länger, Martin Wepler, Michael Westhoff et al. · 2020 · Der Pneumologe
An overview of antiviral strategies for coronavirus 2 (SARS‐CoV‐2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine
Viktorija M. Dragojevic-Simic, Milijana N. Miljković, Dušica Stamenković, Berislav Vekić, Nenad Ratković, Radoje Simić, Nemanja Rančić · 2020 · International Journal of Clinical Practice
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, Claudia Ciancarella, Fabrizio Conti, Cristiano Alessandri · 2020 · Frontiers in Pharmacology
Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission
Kei Yamamoto, Michiyo Suzuki, Gen Yamada, Tsutomu Sudo, Hidetoshi Nomoto, Noriko Kinoshita, Keiji Nakamura, Yoshie Tsujimoto, Yusaku Kusaba, Chie Morita et al. · 2021 · International Journal of Infectious Diseases
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19
Markus F. Blaess, Lars Kaiser, Oliver Sommerfeld, René Csük, Hans‐Peter Deigner · 2021 · International Journal of Molecular Sciences
Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials
Mengzhu Zhao, Chen Zhao, Shuang-shuang Tu, Xuxu Wei, Hongcai Shang · 2021 · Journal of Chinese Integrative Medicine
Protons to Patients: targeting endosomal Na+/H+ exchangers against COVID‐19 and other viral diseases
Hari Prasad · 2021 · FEBS Journal
In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
Yusuf Şımşek, Sahra Setenay Baran, Belma Aslım · 2021 · Journal of Molecular Graphics and Modelling
Natural Products and Nanotechnology Against Coronavirus Disease 2019
Ning Zeng, Xue Chen, Zeming Liu · 2022 · Frontiers in Chemistry
Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19
Xiuge Gao, Xian Jing, Junqi Wang, Yuling Zheng, Yawei Qiu, Hui Ji, Lin Peng, Shanxiang Jiang, Wenda Wu, Dawei Guo · 2022 · Chemico-Biological Interactions
Why Trust Raoult? How Social Indicators Inform the Reputations of Experts
T. Y. Branch, Gloria Origgi, Tiffany Morisseau · 2022 · Social Epistemology
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, Preeti Khanal, Sheriza N. Baksh, Nichol A. McBee, Joshua B. Gruber, Marianne Reid Gildea et al. · 2022 · PLoS ONE
Repurposing of drugs for COVID-19: a systematic review and meta-analysis
Pinky Kotecha, Alexander Light, Enrico Checcucci, Daniele Amparore, Cristian Fiori, Francesco Porpiglia, Prokar Dasgupta A, Oussama Elhage · 2021 · Panminerva Medica
Reporting and design of randomized controlled trials for COVID-19: A systematic review
Alison Dillman, Jay Park, Michael J. Zoratti, Noor-E Zannat, Zelyn Lee, Louis Dron, Grace G. Hsu, Gerald Smith, Sahand Khakabimamaghani, Ofir Harari et al. · 2020 · Contemporary Clinical Trials
Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID‐19: A simulation study
Junichi Okada, Takashi Yoshinaga, Takumi Washio, Kohei Sawada, Seiryo Sugiura, Toshiaki Hisada · 2021 · Clinical and Translational Science
Case Report: Use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 patient
Carlos A. Puyo, Danielle Kreig, Venugopal Saddi, Essam Ansari, Oliver A. Prince · 2020 · F1000Research
FAKE NEWS AND INFODEMIA IN TIMES OF COVID-19 IN BRAZIL: MINISTRY OF HEALTH INDICATORS
José de Ribamar Ross, Marco Aurélio Palazzi Sáfadi, Natália Pereira Marinelli, Layana Pachêco de Araújo Albuquerque, Francisca Miriane de Araújo Batista, Malvina Thaís Pachêco Rodrigues · 2021 · Reme Revista Mineira de Enfermagem
The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic
George John Kontoghiorghes, Stella Fetta, Christina Kontoghiorghe · 2021 · Frontiers in Bioscience-Landmark
Advancements in organs-on-chips technology for viral disease and anti-viral research
Jing Li, Haiqing Bai, Zihao Wang, Xu Beibei, Kristen N. Peters Olson, Chengyao Liu, Yinlei Su, Jiawei Hao, Jinying Shen, Xuetong Xi et al. · 2023 · Organs-on-a-Chip
COVID-19: An Update about the Discovery Clinical Trial
Jean Jacques Vanden Eynde · 2020 · Pharmaceuticals
Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges
Raymond Y. Chang, Wei‐Zen Sun · 2020 · Drug Discovery Today
Recent exposure to smoking and COVID-19
Giovanni Landoni, Matteo Moro, Alessandro Belletti, Patrizia Querini Rovere, Giulia Veronesi, Annalisa Ruggeri, Rosalba Lembo, G D'alessandro, Carola Galbiati, Ary Serpa Neto et al. · 2020 · Critical Care and Resuscitation
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
Faizan Mazhar, Muhammad Abdul Hadi, Chia Siang Kow, Albaraa Mohammed N. Marran, Hamid A. Merchant, Syed Shahzad Hasan · 2020 · International Journal of Infectious Diseases
Does hydroxychloroquine still have any role in the COVID-19 pandemic?
William HK Schilling, Nicholas John White · 2021 · Expert Opinion on Pharmacotherapy
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
Filipe Ferrari, Vítor Magnus Martins, Flávio Danni Fuchs, Ricardo Stein · 2021 · Clinics
Mechanism of Blood–Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury
Rubens P. Homme, Akash K. George, Mahavir Singh, Irina A. Smolenkova, Yuting Zheng, Sathnur Basappa Pushpakumar, Suresh C. Tyagi · 2021 · International Journal of Molecular Sciences
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review
Sergio Marín, Alba Martin Val, Maite Bosch Peligero, Cristina Rodríguez-Bernuz, Ariadna Pérez‐Ricart, Laia Vilaró Jaques, Roger Paredes, Josep Roca, Carles Quiñones · 2022 · Pharmaceuticals
Stem cell therapy in coronavirus disease 2019: current evidence and future potential
Rohit Shetty, Ponnalagu Murugeswari, Koushik Chakrabarty, Chaitra Jayadev, Himanshu P Matalia, Arkasubhra Ghosh, Debashish Das · 2020 · Cytotherapy
Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
J. Cardona-Ospina, Diana M. Rojas-Gallardo, S. Garzón-Castaño, E. Jiménez-Posada, A. Rodriguez-Morales · 2021 · Human Vaccines & Immunotherapeutics
Antibacterial agents used in COVID-19: A systematic review and meta-analysis
Swati Sharma, Aradhana Singh, Tuhina Banerjee · 2021 · Environmental Sustainability
Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
Peng Yin, Juan Meng, Jincheng Chen, Junxiao Gao, Dongqi Wang, Shuyan Liu, Qinglong Guo, Muchun Zhu, Gengwei Zhang, Yingxia Liu et al. · 2021 · Virology Journal
Hydroxychloroquine use in the COVID-19 patient
Emily Littlejohn · 2020 · Cleveland Clinic Journal of Medicine
COVID-19 Coronavirus: Is Infection along with Mycoplasma or Other Bacteria Linked to Progression to a Lethal Outcome?
Garth L. Nicolson, Gonzalo Ferreira · 2020 · International Journal of Clinical Medicine
Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns
Ewa Anita Jankowska, Radosław Sierpiński, Michał Tkaczyszyn, Marcin Drozd, Joanna Szachniewicz, Marta Duda-Sikuła, Brygida Knysz, Krzysztof Adam Simon, Leszek Szenborn, Piotr P. Ponikowski · 2020 · Kardiologia Polska
Chloroquine nasal drops in asymptomatic & mild COVID-19
Alok Thakar, Smriti Panda, Pirabu Sakthivel, Megha Brijwal, Shivram Dhakad, Avinash Choudekar, Anupam Kanodia, Sushma Bhatnagar, Anant Mohan, SubirK Maulik et al. · 2021 · The Indian Journal of Medical Research
Pharmaceuticals in the marine environment: occurrence, fate, and biological effects
Elena Fabbri, Paola Valbonesi, Thomas W. Moon · 2023 · Elsevier eBooks
A 21st Century Evil: Immunopathology and New Therapies of COVID-19
Taylon Felipe Silva, Fernanda Tomiotto‐Pellissier, Raquel Arruda Sanfelice, Manoela Daiele Gonçalves, Bruna Taciane da Silva Bortoleti, Mariana Barbosa Detoni, Ana Carolina Jacob Rodrigues, Amanda Cristina Machado Carloto, Virgínia Márcia Concato, Elaine da Silva Siqueira et al. · 2020 · Frontiers in Immunology
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial
Hoyt Burdick, Carson Lam, Samson J. Mataraso, Anna C. Siefkas, Gregory Lee Braden, R. Phillip Dellinger, Andrea McCoy, Jean‐Louis Vincent, Abigail Green‐Saxena, Gina Barnes et al. · 2020 · Journal of Clinical Medicine
Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression
Torki Al-Otaibi, Osama Ashry Ahmed Gheith, Mohammed M Abuelmagd, Mohammed Adel, Ahmed K E A Alqallaf, N. Elserwy, Mohamed Shaker, Ahmad M. Abbas, Ayman Maher Nagib, Prasad M. Nair et al. · 2021 · Clinical Transplantation
Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage
Kun Wang, Jiajing Wu, XinZHANG, Qingxuan Zeng, Na Zhang, Weijin Huang, Sheng Tang, Yanxiang Wang, Wei–Jia Kong, Youchun Wang et al. · 2021 · Bioorganic Chemistry
Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients
Federico Romano, Salvatore DʼAgate, Oscar E. Della Pasqua · 2021 · Pharmaceutics
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
Moein Shirzad, Marjan Nourigorji, Atefe Sajedi, Maryam Ranjbar, Faeze Rasti, Zahra Sourani, Mona Moradi, Seyed Mostafa Mir, Mohammad Yousef Memar · 2022 · International Immunopharmacology
Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis
Sanjana Nagraj, Dimitrios Varrias, Gabriel Hernández Romero, Heitor Tavares Santos, Dimitrios Karamanis, Dimitrios Sagris, Eleni Korompoki, Haralampos J. Milionis, Leonidas Palaiodimos, George Ntaios · 2022 · Stroke
Prediction of tsunami of resistance to some antibiotics is not far‐fetched which used during COVID‐19 pandemic
Mandana Hosseini, Mohammed Ahmed Hamad, Golazin Mohseni, Shakiba Salamy, Shabnam Dehghan Tarzjani, Majid Taati Moghadam · 2023 · Journal of Clinical Laboratory Analysis
Hydroxychloroquine and COVID-19 – A narrative review
Jyoti Bajpai, Akshyaya Kumar Pradhan, Abhishek Singh, Surya Kant · 2020 · Indian Journal of Tuberculosis
Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
Waqas Ullah, Hafez Mohammad Ammar Abdullah, Sohaib Roomi, Yasar Sattar, Talal Almas, Smitha Narayana Gowda, Rehan Saeed, Maryam Mukhtar, Ammar Ahmad, Tony Oliver et al. · 2020 · Journal of Clinical Medicine Research
The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications
Sohil Ahmed Khan, Michael R. Gionfriddo, Nicolas W. Cortes-Penfield, Girish Thunga, Muhammed Rashid · 2020 · Expert Opinion on Pharmacotherapy
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
Ernesto Carafoli · 2020 · Biochemical and Biophysical Research Communications
4-Aminoquinoline compounds from the Spanish flu to COVID-19
Roberto Barbosa Bazotte, Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Raquel Bragante Gritte, Talita Souza‐Siqueira, Renata Gorjão, Laureane Nunes Masi, Marina Masetto Antunes, Vínicius Fernandes Cruzat, Tânia Cristina Pithon‐Curi et al. · 2020 · Biomedicine & Pharmacotherapy
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic
Matthew F Pullen, Katelyn A Pastick, Darlisha A Williams, Alanna A Nascene, Ananta Shrikant Bangdiwala, Elizabeth C Okafor, Katherine Huppler Hullsiek, Caleb P Skipper, Sarah M Lofgren, Nicole Wyman Engen et al. · 2020 · Open Forum Infectious Diseases
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
Ahsan Naveed, Deeba Naz, Sajjad Ur Rahman · 2021 · Translational Medicine Communications
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Irene García-García, Pilar Guerra‐García, Cristina Ferreras, Alberto Manuel Borobia, Antonio J. Carcas, Javier Queiruga‐Parada, J. L. Vicario, Isabel Mirones, Carlos Solano, Cristina Eguizábal et al. · 2021 · Trials
Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Wu, Min, Li, Changlong, Hur, Junguk · 2020 · arXiv
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence
Amanda Baroutjian, Carol Sanchez, Dessy Boneva, Mark McKenney, Adel Elkbuli · 2020 · The American Journal of Emergency Medicine
Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
Min Joo Choi, Minsun Kang, So Youn Shin, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Jaehun Jung, Joon Young Song · 2020 · International Journal of Infectious Diseases
Biology and Behavior of Severe Acute Respiratory Syndrome Coronavirus Contagion with Emphasis on Treatment Strategies, Risk Assessment, and Resilience
James Baldwin, Samina Noorali, Ashok Vaseashta · 2023 · COVID
Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
Mahdieh Razmi, Farideh Hashemi, Elmira Gheytanchi, Masoumeh Dehghan Manshadi, Roya Ghods, Zahra Madjd · 2020 · International Immunopharmacology
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
Courtney M. Campbell, Avirup Guha, Tamanna Zohra Haque, Tomas G. Neilan, Daniel Addison · 2020 · Journal of Clinical Medicine
COVID-19: What Do Rheumatologists Need to Know?
Gillian E. Fitzgerald, Sinead Maguire, Nigil Haroon · 2021 · Current Rheumatology Reports
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort
Abdulkarim Abdulrahman, Islam AlSayed, Marwa Ali Almadhi, Jumana AlArayed, Sara Mohammed, Aesha Khalid Sharif, Khadija Alansari, Abdulla Ismaeel AlAwadhi, Manaf AlQahtani · 2021 · Infectious Diseases and Therapy
Therapeutic Strategies in the Management of COVID-19
Rajashri R. Naik, Ashok K. Shakya · 2021 · Frontiers in Molecular Biosciences
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, Li-Ping Jiang, Zanxian Xia, Xiao-Juan Xiao, Jing Liu et al. · 2021 · Frontiers in Pharmacology
Knowledge, risk perception and adherence to COVID-19 prevention advisory among police officers in Makurdi Metropolis Benue State, 2020.
Ubong Akpan Okon, Christiana Onche, Simeon Whenayon Ajisegiri, Uche Ifeoma Katchy, Peter Onyema, Charles Chukwudi Uwazie, Anastasia Ikilishi Isika, Araga Abdullahi, Muhammad Shakir Balogun · 2021 · PubMed Central
COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy
Koel Sinha, Sutapa Som Chaudhury, Pramita Sharma, Bhuban Ruidas · 2021 · Journal of Pharmaceutical Analysis
Analysis of COVID-19 Guideline Quality and Change of Recommendations: A Systematic Review
Siya Zhao, Shuya Lu, Shouyuan Wu, Zijun Wang, Qiangqiang Guo, Qianling Shi, Hairong Zhang, Juanjuan Zhang, Hui Liu, Yunlan Liu et al. · 2021 · Health Data Science
Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
Kateřina Bogdanová, Lenka Doubravská, Iva Vágnerová, Kristýna Hricová, Vendula Pudová, Magdaléna Röderová, Jan Papajk, Radovan Uvízl, Kateřina Langová, Milan Kolář · 2021 · Life
Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions
Aditya Reddy Kolli, Tanja Živković Semren, David Bovard, Shoaib Majeed, Marco van der Toorn, Sophie Scheuner, Philippe A. Guy, Arkadiusz K. Kuczaj, Anatoly A. Mazurov, Stefan Frentzel et al. · 2022 · The AAPS Journal
Increase in Ca2+-Activated cAMP/PKA Signaling Prevents Hydroxychloroquine-Induced Bradycardia of the Cardiac Pacemaker
Sofia Segal, Limor Arbel-Ganon, Savyon Mazgaoker, Moran Davoodi, Yael Yaniv · 2022 · Frontiers in Physiology
Educational case series of electrocardiographs during the COVID-19 pandemic and the implications for therapy
CH Sia, Jinghao Nicholas Ngiam, Nicholas Chew, DLL Beh, Kian Keong Poh · 2020 · Singapore Medical Journal
QTc Prolongation in COVID-19 Patients Using Chloroquine
Matthijs L. Becker, Dominic Snijders, Claudia van Gemeren, Hylke Jan Kingma, Steven F. L. van Lelyveld, Thijs J. Giezen · 2021 · Cardiovascular Toxicology
Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus
Ai-Min Shi, Rui Guo, Qiang Wang, Jin‐Rong Zhou · 2021 · Biomolecules
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials
Nida Bokharee, Yusra Habib Khan, Aisha Khokhar, Tauqeer Hussain Mallhi, Nasser Hadal Alotaibi, Maria Rasheed · 2021 · Expert Review of Anti-infective Therapy
COVID-19, Health Care and Self-Medication Issues in Resource-Limited Settings
Israel Abebrese Sefah, Darius Obeng Essah, Mainul Haque, Sylvia Adisa Opanga, Santosh Kumar, Ibrahim Chikowe, Dan Kibuule, Enos Muisaphanda Rampamba, Aubrey Chichonyi Kalungia, Thuy Nguyen Thi Phuong et al. · 2021 · Advances in Human Biology
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil
Gecilmara Salviato Pileggi, Gilda Aparecida Ferreira, Ana Paula Monteiro Gomides, Edgard Torres dos Reis-Neto, Mirhelen Mendes de Abreu, Cleandro Pires de Albuquerque, Nafice Costa Araújo, Ana Beatriz Santos Bacchiega, Dante Valdetaro Bianchi, Blanca Elena Ríos Gomes Bica et al. · 2021 · Revista Brasileira de Reumatologia
Preventing the Next Pandemic: The Case for Investing in Circulatory Health – A Global Coalition for Circulatory Health Position Paper
Leslie Rae Ferat, R. Forrest, K. Sehmi, R. D. Santos, D. Stewart, A. Boulton, Beatriz Yáñez Jiménez, Phillip F. Riley, D. Burger, E. Jones et al. · 2021 · Global Heart
SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy—Is there a link?
Bianca Depieri Balmant, Raquel Susana Torrinhas, Ilanna Marques Gomes da Rocha, Danielle Cristina Fonseca, Francisco Fellipe Claudino Formiga, Eloísa Bonfá, Eduardo Ferreira Borba, Dan Linetzky Waitzberg · 2020 · Nutrition
Impact of Hypertension on Progression and Prognosis in Patients with COVID-19 A Retrospective Cohort Study in 1031 Hospitalized Cases in Wuhan, China
Hesong Zeng, Tianlu Zhang, Xingwei He, Yuxin Du, Yan Tong, Xueli Wang, Weizhong Zhang, Yin Shen · 2020 · medRxiv
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation
Gennaro DE PASCALE, Salvatore Lucio Cutuli, Simone Carelli, Rikardo Xhemalaj, Tommaso Rosà, Giuseppe Bello, Joel Vargas, Melania Cesarano, Luca Maria Montini, Eloisa Sofia Tanzarella et al. · 2022 · PLoS ONE
Prevalence of Self-Medication and Associated Factors among Healthcare Students during the COVID-19 Pandemic: A Cross-Sectional Study at the University of Zambia
Steward Mudenda, Victor Daka, Scott Kaba Matafwali, Manal Hadi Ghaffoori Kanaan, Sura Saad Abdullah, Shafiq Mohamed, Webrod Mufwambi, Maisa Kasanga, Ben Mulenga, Billy Chabalenge et al. · 2023 · Open Journal of Social Sciences
Treatment of COVID 19—Repurposing drugs commonly used in dermatology
Jelena Stojković‐Filipović, Martina Bosić · 2020 · Dermatologic Therapy
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin
Jacob E. Simmering, Linnea A. Polgreen, Philip M. Polgreen, Rebecca Teske, Alejandro P. Comellas, Barry L. Carter · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19
Rajesh Rajaiah, Kandahalli Venkataranganayaka Abhilasha, Mysore A. Shekar, Stefanie N. Vogel, Bannikuppe Sannanaik Vishwanath · 2020 · Cellular Immunology
A Narrative Review of Emerging Therapeutics for COVID-19
Van C. Willis, Yull Edwin Arriaga, Dilhan Weeraratne, F. Leonardi Reyes, Gretchen Purcell Jackson · 2020 · Mayo Clinic Proceedings Innovations Quality & Outcomes
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Chunfeng Li, Genhong Cheng · 2020 · Frontiers in Immunology
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down
Antonis S. Manolis, Theodora A. Manolis, Antonis S. Manolis, Helen Melita · 2020 · Current Opinion in Cardiology
Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
Jiuyang Xu, Bin Cao · 2021 · European Respiratory Journal
COVID-19 and Cardiac Arrhythmias
Nitin Kumar Parashar, Shekhar Kunal, Himanshu Mahla, Kashish Gupta, Vijay Pathak · 2021 · European Journal of Arrhythmia & Electrophysiology
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
Pia Clara Pafundi, Raffaele Galiero, Vittorio Simeon, Luca Rinaldi, Alessandro Perrella, Erica Vetrano, Alfredo Caturano, Maria Alfano, Domenico Beccia, Riccardo Nevola et al. · 2021 · PLoS ONE
Implementation of a fully remote randomized clinical trial with cardiac monitoring
Jacob J. Mayfield, Neal A. Chatterjee, Peter A. Noseworthy, Jeanne E. Poole, Michael John Ackerman, Jenell C Stewart, PATRICIA J. KISSINGER, John Dwyer, Sybil Hosek, Temitope Oyedele et al. · 2021 · Communications Medicine
A comprehensive review of adverse events to drugs used in COVID‐19 patients: Recent clinical evidence
Renato Ferreira‐da‐Silva, Inês Ribeiro‐Vaz, Manuela Morato, Jorge Junqueira Polónia · 2022 · European Journal of Clinical Investigation
COVID‑19: Main findings after a year and half of unease and the proper scientific progress (Review)
Marius Traian Leretter, Dan Dumitru Vulcănescu, Florin George Horhat, Anamaria Matichescu, Mircea Riviș, Laura Cristina Rusu, Alexandra Roi, Robert Cosmin Racea, Ioana Badea, Cristina Adriana Dehelean et al. · 2022 · Experimental and Therapeutic Medicine
Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020
Rosa Maria Vivanco‐Hidalgo, Israel Molina, Elisenda Martínez-Carbonell, Ramón Roman-Viñas, Adrián Sánchez‐Montalvá, Joan Fibla, Caridad Pontes, César Velasco, on behalf of the Real World Data Working Group · 2021 · Eurosurveillance
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
Gian Luca Erre, Edoardo Sean Ferraccioli, Matteo Piga, Arduino Aleksander Mangoni, Giuseppe Passiu, Elisa Gremese, Gianfranco Ferraccioli · 2020 · Annals of the Rheumatic Diseases